1992 - Fellow of the American Statistical Association (ASA)
Her primary scientific interests are in Internal medicine, Stroke, Placebo, Surgery and Physical therapy. Barbara C. Tilley has included themes like Tissue plasminogen activator, Central nervous system disease and Ischemia in her Stroke study. Her work deals with themes such as Odds ratio, Clinical trial, Randomized controlled trial, Blood pressure and Meta-analysis, which intersect with Placebo.
Her Surgery research integrates issues from Hazard ratio, Anesthesia, Fibrinolytic agent and Cardiology. Her Physical therapy study combines topics from a wide range of disciplines, such as Interim analysis, Severity of illness, Creatine and Rating scale. Her study on Rating scale also encompasses disciplines like
Internal medicine, Clinical trial, Physical therapy, Surgery and Stroke are her primary areas of study. Her research integrates issues of Placebo, Oncology and Cardiology in her study of Internal medicine. Her Clinical trial study also includes
Her Physical therapy research incorporates elements of Quality of life, Severity of illness and Rating scale. Her Rating scale study also includes fields such as
Her primary areas of study are Clinical trial, Rating scale, Randomized controlled trial, Physical therapy and Unified Parkinson's disease rating scale. Her Clinical trial study incorporates themes from Psychological intervention, Alternative medicine, Informed consent, Medical education and Stroke. The concepts of her Stroke study are interwoven with issues in Placebo and Tissue plasminogen activator.
Her Randomized controlled trial study results in a more complete grasp of Surgery. Her study in Surgery is interdisciplinary in nature, drawing from both Anesthesia and Hazard ratio. Her study looks at the relationship between Unified Parkinson's disease rating scale and topics such as Clinical psychology, which overlap with Cronbach's alpha.
Her scientific interests lie mostly in Rating scale, Physical therapy, Randomized controlled trial, Clinical trial and Unified Parkinson's disease rating scale. Her Rating scale study integrates concerns from other disciplines, such as Concordance, Cognition and Parkinson's disease. The various areas that Barbara C. Tilley examines in her Physical therapy study include Cross-sectional study, Quality of life, Modified Rankin Scale, Movement disorders and Rank correlation.
Her Randomized controlled trial study contributes to a more complete understanding of Surgery. Her Clinical trial study combines topics in areas such as Health equity, Thrombolysis, Patient education and Hazard ratio. Her study on Stroke is covered under Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins.
Movement Disorders (2008)
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials
Werner Hacke;Geoffrey Donnan;Cesare Fieschi;Markku Kaste.
The Lancet (2004)
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
Kennedy R Lees;Erich Bluhmki;Rüdiger von Kummer;Thomas G Brott.
The Lancet (2010)
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson;Kennedy R Lees;Patrick Lyden;Lisa Blackwell.
The Lancet (2014)
Transfusion of plasma, platelets, and red blood cells in a 1: 1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: The PROPPR randomized clinical trial
John B. Holcomb;Barbara C. Tilley;Sarah Baraniuk;Erin E. Fox.
JAMA (2015)
Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.
Patrick Lyden;T. Brott;B. Tilley;K. M A Welch.
Stroke (1994)
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
Christopher G. Goetz;Stanley Fahn;Pablo Martinez-Martin;Werner Poewe.
Movement Disorders (2007)
Effects of tissue plasminogen activator for acute ischemic stroke at one year
Thomas G. Kwiatkowski;Richard B. Libman;Michael Frankel;Barbara C. Tilley.
The New England Journal of Medicine (1999)
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
Askiel Bruno;S. R. Levine;M. R. Frankel;T. G. Brott.
Neurology (2002)
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale
Glenn T. Stebbins;Christopher G. Goetz;David J. Burn;Joseph Jankovic.
Movement Disorders (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Rush University Medical Center
Rush University Medical Center
SUNY Downstate Medical Center
University of Florida
University of Cincinnati
Henry Ford Health System
University of Southern California
Instituto de Salud Carlos III
The University of Texas Health Science Center at Houston
Mayo Clinic
University of Southern California
École Nationale de la Statistique et de l'Administration Économique
World Bank
Johnson & Johnson (United States)
Utrecht University
Chinese Academy of Sciences
National Institutes of Health
KU Leuven
Radboud University Nijmegen
Texas Medical Center
University of Chicago
Stanford University
University of Western Australia
National University of Ireland, Galway
University of Rome Tor Vergata
Cornell University